So‑Cheong‑Ryong‑Tang, a herbal medicine, modulates inflammatory cell infiltration and prevents airway remodeling via regulation of interleukin‑17 and GM‑CSF in allergic asthma in mice

Background: So‑Cheong‑Ryong‑Tang (SCRT), herbal medicine, has been used for the control of respiratory disease in East Asian countries. However, its therapeutic mechanisms, especially an inhibitory effect on inflammatory cell infiltration and airway remodeling in allergic asthma are unclear. Objective: The present study investigated the mechanism of antiasthmatic effects of SCRT in allergic asthma in mice. Materials and Methods: We investigated the influence of SCRT on levels of interleukin‑17 (IL‑17), granulocyte/macrophage colony‑stimulating factor (GM‑CSF), IL‑4, and interferon gamma (IFN‑γ) in bronchoalveolar lavage fluid (BALF), ovalbumin (OVA)‑specific IgE in serum, and histopathological changes in allergen‑induced asthma. Results: So‑Cheong‑Ryong‑Tang decreased levels of IL‑17 and GM‑CSF in BALF. IL‑4, a Th2‑driven cytokine, was also decreased by SCRT, but IFN‑γ, a Th1‑driven cytokine, was not changed. Levels of OVA‑specific IgE in serum were also decreased by SCRT. With SCRT treatment, histopathological findings showed reduced tendency of inflammatory cell infiltration, and prevention from airway remodeling such as epithelial hyperplasia. Conclusion: In this study, we firstly demonstrated that regulation of IL‑17 and GM‑CSF production may be one of the mechanism contributed to a reduction of inflammatory cell infiltration and prevention from airway remodeling.